There were 1,539 press releases posted in the last 24 hours and 413,213 in the last 365 days.

Medicis Proxy Materials Available Online

April 13, 2010 (FinancialWire) — Medicis (NYSE: MRX) said proxy materials are available via the Internet for its 2010 annual meeting of stockholders under the U.S. Securities and Exchange Commission's notice and access rule.

Under this rule, the SEC provides companies the option of delivering a "Notice of Internet Availability of Proxy Materials" to stockholders, providing stockholders with Internet access to proxy materials and providing a printed set of proxy materials to stockholders only upon request.

The Medicis 2010 annual meeting of Stockholders is scheduled for Tuesday, May 18, 2010, 9: 30 a.m. (Pacific Time) at the Scottsdale Resort and Conference Center, 7700 East McCormick Parkway, Scottsdale, AZ 85258.

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[frlylrf] [biomedphrm] [nwprdctstc]